30th week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190224176 | COMBINATION CONTAINING SGC ACTIVATORS AND MINERALOCORTICOID RECEPTOR ANTAGONISTS | 2019-07-25 |
20190224177 | STABLE LIQUID COMPOSITIONS OF SODIUM PICOSULFATE | 2019-07-25 |
20190224178 | ALTERING EXPRESSION LEVEL OF GLUTATHIONE S-TRANSFERASE GENES BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | 2019-07-25 |
20190224179 | DECREASING EXPRESSION LEVEL OF PROTEASOME SUBUNIT GENES BY TREATING A HUMAN SUBJECT WITH A NITROXIDE | 2019-07-25 |
20190224180 | Non-Aqueous Liquid Nimodipine Compositions | 2019-07-25 |
20190224181 | TOPICAL RETINOID COMPOSITIONS | 2019-07-25 |
20190224182 | HAIR FOLLICLE STEM CELL ACTIVATION AND HAIR GROWTH | 2019-07-25 |
20190224183 | Methods of Managing Conditioned Fear with Neurokinin Receptor Antagonists | 2019-07-25 |
20190224184 | PREPARATION OF (-)-COCAINE HYDROCHLORIDE | 2019-07-25 |
20190224185 | PREPARATION OF (-)-COCAINE HYDROCHLORIDE | 2019-07-25 |
20190224186 | TREATMENT OF MULTIPLE SCLEROSIS WITH CHS-131 | 2019-07-25 |
20190224187 | NEW USE OF ISOQUINOLINE DERIVATIVES FOR WOUND HEALING | 2019-07-25 |
20190224188 | SUBSTITUTED HETEROCYCLES AS ANTIVIRAL AGENTS | 2019-07-25 |
20190224189 | USE OF TYROSINE-KINASE INHIBITOR IN PREPARING PHARMACEUTICAL PRODUCT FOR CANCER TREATMENT | 2019-07-25 |
20190224190 | PYRIDINYL AND FUSED PYRIDINYL TRIAZOLONE DERIVATIVES | 2019-07-25 |
20190224191 | MECLOZINE DERIVATIVES AND DICLAZURIL DERIVATIVES FOR USE IN THE PREVENTION AND/OR THE TREATMENT OF DISORDERS ASSOCIATED TO THE INFLAMMATION INDUCED BY P. ACNES | 2019-07-25 |
20190224192 | Stable Pharmaceutical Composition of Vortioxetine Hydrobromide | 2019-07-25 |
20190224193 | Compositions of Natural Extracts and Use Thereof in Methods for Preventing or Treating Diseases | 2019-07-25 |
20190224194 | COMPOSITION FOR TREATING OCULAR DISEASES AND METHODS OF USAGE AND MAKING | 2019-07-25 |
20190224195 | Oral Capsule Composite Formulation of Dutasteride and Tadalafil | 2019-07-25 |
20190224196 | TREATMENT OF PROSTATE CANCER | 2019-07-25 |
20190224197 | SUBSTITUTED AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | 2019-07-25 |
20190224198 | CAP-DEPENDENT ENDONUCLEASE INHIBITORS | 2019-07-25 |
20190224199 | MELANIN PRODUCTION INHIBITOR, WHITENING AGENT, FIBROBLAST ACTIVATOR, COLLAGEN AND/OR ELASTIN PRODUCTION PROMOTER AND WRINKLE AMELIORANT | 2019-07-25 |
20190224200 | COMBINATIONS FOR THE TREATMENT OF CANCER | 2019-07-25 |
20190224201 | PHARMACEUTICAL COMPOSITION COMPRISING NEPTINIB OR SALT THEREOF AND METHOD FOR CONTROLLING IMPURITY THEREOF | 2019-07-25 |
20190224202 | STABLE LIQUID FORMULATIONS OF PEMETREXED | 2019-07-25 |
20190224203 | Methods of Treating Steroid Resistant Diseases and Conditions | 2019-07-25 |
20190224204 | PHARMACEUTICAL COMPOSITIONS OF IBRUTINIB | 2019-07-25 |
20190224205 | COMPOSITIONS AND METHODS OF TREATING CANCER | 2019-07-25 |
20190224206 | METABOLITES OF BICTEGRAVIR | 2019-07-25 |
20190224207 | MULTIFUNCTIONAL INHIBITORS OF MEK/PI3K AND mTOR/MEK/PI3K BIOLOGICAL PATHWAYS AND THERAPEUTIC METHODS USING THE SAME | 2019-07-25 |
20190224208 | PHARMACEUTICAL COMPOSITION FOR TREATING PREMATURE EJACULATION AND METHOD FOR TREATING PREMATURE EJACULATION | 2019-07-25 |
20190224209 | COMBINATION THERAPY OF TETRACYCLIC QUINOLONE ANALOGS FOR TREATING CANCER | 2019-07-25 |
20190224210 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN PREVENTING OR TREATING BACTERIAL INFECTIONS | 2019-07-25 |
20190224212 | Nrf2 REGULATORS | 2019-07-25 |
20190224213 | VAGINAL COMPOSITION COMPRISING A COMBINATION OF ESTROGEN AND VITAMIN D | 2019-07-25 |
20190224214 | HUMAN GHRELIN O-ACYLTRANSFERASE INHIBITORS | 2019-07-25 |
20190224215 | NEEDLE ASSISTED JET INJECTION ADMINISTRATION OF TESTOSTERONE COMPOSITIONS | 2019-07-25 |
20190224216 | COMPOSITIONS COMPRISING ACIDIC EXTRACTS OF MASTIC GUM AND USES THEREOF FOR TREATING OPTIC NEUROPATHY | 2019-07-25 |
20190224217 | COMPOSITIONS COMPRISING TRITERPENOIDS AND USES THEREOF FOR TREATING OPTIC NEUROPATHY | 2019-07-25 |
20190224218 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | 2019-07-25 |
20190224219 | ORAL COMPOSITION OF CELECOXIB FOR TREATMENT OF PAIN | 2019-07-25 |
20190224220 | Carbidopa and L-Dopa Prodrugs and Methods of Use | 2019-07-25 |
20190224221 | ULTRALOW-POWER NEAR INFRARED LAMP LIGHT OPERABLE TARGETED ORGANIC NANOPARTICLE PHOTODYNAMIC THERAPY | 2019-07-25 |
20190224222 | METHOD OF INHIBITING QUORUM SENSING USING D-GALACTOSE | 2019-07-25 |
20190224223 | ADMINISTRATION OF NICOTINAMIDE MONONUCLEOTIDE IN THE TREATMENT OF DISEASE | 2019-07-25 |
20190224224 | Guanosine as an Immune Potentiator Mediated through Toll Receptors | 2019-07-25 |
20190224225 | ESTERS OF 2-DEOXY-MONOSACCHARIDES WITH ANTI PROLIFERATIVE ACTIVITY | 2019-07-25 |
20190224226 | AMINOGLYCOSIDES AND USES THEREOF IN TREATING GENETIC DISORDERS | 2019-07-25 |
20190224227 | Use of Immobilization Particles for Removal of Microorganisms and/or Chemicals | 2019-07-25 |
20190224228 | LET-7 MICRORNA AND MIMETICS THEREOF AS THERAPEUTICS FOR CANCER | 2019-07-25 |
20190224229 | KEFIRAN FOR USE IN REGENERATIVE MEDICINE AND/OR TISSUE ENGINEERING | 2019-07-25 |
20190224230 | Use of Resistant Potato Starch as a Prebiotic to Modify Microbiota | 2019-07-25 |
20190224231 | HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS | 2019-07-25 |
20190224232 | PROCESS FOR THE PREPARATION AND PURIFICATION OF THE SODIUM SALT OF HYALURONIC ACID | 2019-07-25 |
20190224233 | MATERIALS AND METHODS RELATING TO STABILISED POLYMERIC SILICATE COMPOSITIONS | 2019-07-25 |
20190224234 | SUPPLEMENT FOR TREATING SIDE EFFECTS OF MEDICATIONS WHICH CAUSE METABOLIC ACIDOSIS | 2019-07-25 |
20190224235 | TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID | 2019-07-25 |
20190224236 | CELL-BASED NEOANTIGEN VACCINES AND USES THEREOF | 2019-07-25 |
20190224237 | METHODS OF USE FOR CAR T CELLS | 2019-07-25 |
20190224238 | TUMOR THERAPEUTIC DRUG | 2019-07-25 |
20190224239 | HEAT-EXPOSED PLATELET LYSATE COMPOSITIONS, AND METHODS FOR PREPARING AND USING SAME | 2019-07-25 |
20190224240 | CELL THERAPY FOR THE TREATMENT OF NON-ISCHEMIC HEART FAILURE | 2019-07-25 |
20190224241 | NONVIRAL MINICIRCLE VECTOR CARRYING SOX GENE AND CONSTRUCTION METHOD THEREFOR | 2019-07-25 |
20190224242 | EXOSOMES AND MIRNA TO TREAT GLAUCOMA | 2019-07-25 |
20190224243 | Enhancement of the Beneficial Effects of Mesenchymal Stem Cell Treatment by the Caveolin-1 Scaffolding Domain Peptide and Subdomains | 2019-07-25 |
20190224244 | CELL COMPOSITIONS FOR TISSUE REGENERATION | 2019-07-25 |
20190224245 | System and Methods for Preparation of Adipose-Derived Stem Cells | 2019-07-25 |
20190224246 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES | 2019-07-25 |
20190224247 | METHODS AND COMPOSITIONS FOR PROVISION OF ANGIOGENIC FACTORS | 2019-07-25 |
20190224248 | CARTILAGE REGENERATION USING CHONDROCYTE AND TGF-BETA | 2019-07-25 |
20190224249 | TREATMENT OF INTERVERTEBRAL DISC DEGENERATION | 2019-07-25 |
20190224250 | COMPOSITION FOR INJECTION WHICH CAN BE USED FOR TREATMENT OF HEART DISEASES AND CONTAINS FIBROBLASTS, AND METHOD FOR PRODUCING FIBROBLAST FOR THERAPY USE | 2019-07-25 |
20190224251 | METHODS OF DIFFERENTIATING STEM CELLS INTO ENDODERM | 2019-07-25 |
20190224252 | BACTERIAL PROFILE TO DETECT FUNGAL TAXA ABUNDANCE IN THE GUT | 2019-07-25 |
20190224253 | COMPOSITIONS AND METHODS OF TREATING CANCER USING BIFIDOBACTERIUM ANIMALIS SSP. LACTIS | 2019-07-25 |
20190224254 | METHOD FOR FACILITATING MATURATION OF THE MAMMALIAN IMMUNE SYSTEM | 2019-07-25 |
20190224255 | METHOD FOR PREVENTING OR TREATING COLITIS DISEASE COMPRISING LACTOBACILLUS SAKEI K040706 AS AN ACTIVE INGREDIENT | 2019-07-25 |
20190224256 | GENERATION OF NEURONS BY REPROGRAMMING OF OLIGODENDROCYTES AND OLIGODENDROCYTE PRECURSOR CELLS | 2019-07-25 |
20190224257 | Drug composition for angiogenesis therapy | 2019-07-25 |
20190224258 | NOVEL BACTERIOPHAGE AND COMPOSITION COMPRISING SAME | 2019-07-25 |
20190224259 | FERMENTATION PRODUCT OF PUNICA GRANATUM AND USES THEREOF | 2019-07-25 |
20190224260 | Metabolic Syndrome Inhibitor | 2019-07-25 |
20190224261 | LICORICE EXTRACT COMPOSITIONS AND METHOD OF USE | 2019-07-25 |
20190224262 | Composition Comprising Natural Substances Having Healing, Repellent and Biocidal Properties for the Treatment and the Cure of External Wounds | 2019-07-25 |
20190224263 | COMPOSITION FOR TOPICAL APPLICATION WITH ANTIFUNGAL ACTIVITY | 2019-07-25 |
20190224264 | EXTRACT FROM INDIGO NATURALIS AND A PROCESS FOR PREPARING THE SAME | 2019-07-25 |
20190224265 | METHOD FOR PREPARING TEA LEAF EXTRACT | 2019-07-25 |
20190224266 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTIONS AND MANAGEMENTS OF DEMENTIA, INFECTIOUS DISEASES, CANCERS, PERIODONTITIS, DENTAL CARIES, DIABETES, OBESITY, OSTEOPOROSIS AND CHRONIC PAIN AND METHODS THEREOF | 2019-07-25 |
20190224267 | AN ANTI-INFLAMMATORY COMPOSITION FOR THE TREATMENT OF ACUTE JOINT INFLAMMATION AND A PROCESS FOR PREPARATION THEREOF | 2019-07-25 |
20190224268 | WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES | 2019-07-25 |
20190224269 | INHIBITORS OF IAP | 2019-07-25 |
20190224270 | PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS | 2019-07-25 |
20190224271 | MANUFACTURE OF DEGARELIX | 2019-07-25 |
20190224272 | INHIBITING TUMOR CELL MIGRATION BY INHIBITION OF KINESIN LIGHT CHAIN 1, VARIANT 1 (KLC1C) | 2019-07-25 |
20190224273 | Nutritional Supplements Containing A Peptide Component And Uses Thereof | 2019-07-25 |
20190224274 | MIF INHIBITORS AND METHODS OF USE THEREOF | 2019-07-25 |
20190224275 | PROTOCOL FOR TREATMENT OF LUPUS NEPHRITIS | 2019-07-25 |
20190224276 | ESCALATING DOSAGE SCHEDULES FOR TREATING CELIAC DISEASE | 2019-07-25 |